New Pill-and-Infusion combo aims to tame rare blood cancer without chemo
NCT ID NCT07285590
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a combination of two drugs, pirtobrutinib (a pill) and rituximab (an infusion), in 50 adults newly diagnosed with a slow-growing form of mantle cell lymphoma. The goal is to see if this drug pair can shrink or control the cancer without the need for standard chemotherapy. Participants will receive the treatment for several cycles, and researchers will track how many achieve complete remission after 6 cycles.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA (MCL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Clínica Universidad Navarra
RECRUITINGMadrid, Madrid, 28027, Spain
-
Clínica Universidad Navarra
RECRUITINGPamplona, Pamplona, 31008, Spain
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, Barcelona, 08036, Spain
-
Hospital Clínico Universitario Virgen de la Arrixaca
RECRUITINGEl Palmar, Murcia, 30120, Spain
-
Hospital Clínico de Valencia
RECRUITINGValencia, Valencia, 46010, Spain
-
Hospital Costa del Sol
RECRUITINGMarbella, Málaga, 29603, Spain
-
Hospital General Universitario Gregorio Marañón
RECRUITINGMadrid, Madrid, 28007, Spain
-
Hospital Ramon y Cajal
RECRUITINGMadrid, Madrid, 28034, Spain
-
Hospital Universitari Vall d'Hebron
RECRUITINGBarcelona, Barcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, Madrid, 28041, Spain
-
Hospital Universitario de Salamanca
RECRUITINGSalamanca, Salamanca, 37007, Spain
-
Hospital Universitario y Politécnico La Fe
NOT_YET_RECRUITINGValencia, Valencia, 46026, Spain
-
INSTITUT CATALÀ D'ONCOLOGIA (ICO). Hospital Germans Trias I Pujol.
NOT_YET_RECRUITINGBadalona, Barcelona, 08916, Spain
-
Institut Català d'oncologia de L'Hospitalet (ICO-L'Hospitalet)
NOT_YET_RECRUITINGL'Hospitalet de Llobregat, Barcelona, 08908, Spain
-
Instituto Português de Oncologia de Lisboa Francisco Gentil
RECRUITINGLisbon, Lisbon District, 1099-023, Portugal
-
Unidade Local De Saude De Santa Maria E.P.E.
NOT_YET_RECRUITINGLisbon, Lisbon District, 1649-028, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a chemo-free cocktail tame mantle cell lymphoma?
- Engineered immune cells take on tough lymphomas
- New drug duo aims to outsmart resistant lymphoma
- New combo pill attack aims to control blood cancers
- New CAR-T therapy aims to stop High-Risk lymphoma early
- New drug takes aim at Hard-to-Treat blood cancers